Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The conditions that most commonly support eligibility include: Obesity (BMI 30, or 27 with at least one comorbidity such as hypertension, sleep apnea, or cardiovascular disease) Type 2 diabetes or prediabetes Insulin resistance with clinical documentation Metabolic syndrome (clinically diagnosed) Polycystic Metabolic Ovarian Syndrome (PMOS) and related hormonal disorders Non-alcoholic fatty liver disease (NAFLD/MASLD) Perimenopause-related metabolic dysfunction with documented hormonal changes GLP-1 receptor agonists including semaglutide, tirzepatide, and retatrutide are the most commonly used peptides in metabolic care today
References Wharton S, Lingvay I, Bogdanski P, et al
Dopamine (220 mcg/kg/min IV infusion) Used for bradycardia and hypotension to support cardiac output and blood pressure
El Gohary DSE, Ismail MM, El khayat AM, Elbohoty SB
Gastric emptying remains delayed consistently, which supports portion control and fullness after meals
US$ 21.48
US$ 25.75
US$ 28.67
US$ 28.45
US$ 29.80
US$ 28.72
US$ 26.37
